Navigation Links
Patients Do Better at Hospitals That Follow Stroke Guidelines
Date:2/22/2010

n the use of evidence-based therapies, large variations between different hospitals and different physicians, and disparities in the use of recognized therapies," Fonarow explained. "There were certain patients -- including older patients, women and minorities -- who were less likely to receive recommended therapy."

The recommended steps include:

  • Giving clot-dissolving medication, or intravenous recombinant tissue plasminogen activator (tPA) three hours from the onset of symptoms for those with ischemic stroke.
  • Giving anti-platelet or anticoagulant medication within 48 hours of admission and at discharge.
  • Providing treatments to prevent deep vein thrombosis by the end of day two.
  • Giving patients with atrial fibrillation anticoagulation medications such as Coumadin (warfarin) at discharge.
  • Providing cholesterol-lowering medications such as statins to help prevent additional strokes or heart attacks.
  • Provide smokers with information on smoking cessation.

Additional measures include making sure CT scans get done quickly; offering stroke education to patients and caregivers, including information about prevention and warning signs of stroke; referrals for stroke rehabilitation and screening for swallowing problems.

Since 2003, nearly 1,400 hospitals of the nation's approximately 5,000 community hospitals have pledged to follow the protocols and enter their data into a national registry. Between 2003 and 2009, the percentage of stroke or TIA patients who received all of the recommended treatments increased from 44 percent to 84 percent, while those who received nearly all increased from 72 percent to 93 percent, the researchers reported.

Patients average age was about 72. About 60 percent had an ischemic stroke, which occurs when a blood clot blocks a blood vessel in the brain; nearly 23 percent had a TIA; nearly 11 percent had an intracerebral hemorrhage;
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Fluctuating eye pressure associated with visual field deterioration in glaucoma patients
2. Comparison of obstetric outcomes between on-call and patients own obstetricians
3. Vision restoration therapy shown to improve brain activity in brain injured patients
4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
5. Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia
6. Restricting Blood Flow May Help Heart Bypass Patients
7. Patients with Medicaid and those lacking insurance have higher risk of advanced laryngeal cancer
8. Study provides hope that some transplant patients could live free of antirejection drugs
9. Study provides hope that some transplant patients could live free of anti-rejection drugs
10. Longer ambulance journeys boost death risk for seriously ill patients
11. Expenses Overshadow Optimism for Kidney Failure Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 01, 2015 EBSCO Health , ... introduced DynaMed Plus™ , a cross-platform evidence-based clinical ... It provides clinicians with the ideal blend of evidence ... paths. , DynaMed Plus is a significant enhancement ... the most frequently updated evidence-based content. DynaMed Plus content ...
(Date:6/1/2015)... June 01, 2015 KC and Monica ... $88,000 of the best superfood products in ... floods in Texas. , "Monica and I are ... News in distributing Living Fuel Super Meals - SuperBerry®, ... millennial floods in Texas," KC Craichy said. "We have ...
(Date:6/1/2015)... Atlanta, GA (PRWEB) June 01, 2015 ... leading publisher of clinical journals in the areas of ... pleased to announce that it has expanded upon its ... newest journal, Hospital Medicine Practice, in a mobile ... smartphones and tablets. , “We are very excited ...
(Date:6/1/2015)... The session, entitled “Building the Blueprint ... president of Elektrobit Automotive Americas, senior representatives from ... will be moderated by Andy Gryc of CX3 Marketing. ... complexity of in-vehicle software in connected vehicles and autonomous ... how the wider ecosystem can fit into new vehicle ...
(Date:6/1/2015)... 2015 Strategic Radiology (SR) announced today ... joined forces with the SR coalition of progressive, independent ... alignment, RRG will now have access to collective resources ... clinical quality, and deployment of subspecialized radiology services. With ... member and affiliate US based radiology group practices. ...
Breaking Medicine News(10 mins):Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 2Health News:Nearly $100,000 In Emergency Food Aid to Flood Victims in Texas Provided by Living Fuel and Natural News 3Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 2Health News:EB Medicine Expands Partnership With AgileMD To Launch Hospital Medicine Mobile Application 3Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 2Health News:Elektrobit Automotive, Ford and Delphi to Tackle In-Vehicle Software at TU-Automotive Detroit 2015 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 2Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 3Health News:Rome Radiology Group Aligns with the Strategic Radiology® National Coalition 4
... (NYSE: WST ) today announced that Donald E. ... Federici, Chief,Financial Officer, will be presenting at the 2008 ... 11, 2008 in New York City., A copy ... the,investor link of the Company,s website at http://www.westpharma.com ...
... BIOSAFE Laboratories, Inc.,the developer of the BIOSAFE ... have announced the availability of a limited,number of ... identify diabetic and,pre-diabetic children and adolescents. The BIOSAFE ... an immediate fasting glucose reading and,a mail-in laboratory ...
... IPC The,Hospitalist Company, Inc. (Nasdaq: IPCM ... that it closed its previously announced initial,public offering ... that the,underwriters of the offering have exercised their ... stock from the selling,stockholders at the public offering ...
... (OTC,Bulletin Board: SNKTY), a Life Sciences company engaged ... of healthy aging, today announced,the debut of Pyratine-6(TM) ... of Dermatology in San Antonio, Texas., Pyratine-6(TM), ... to be effective in correcting visible signs of ...
... EnterpriseIQ Supports Device Manufacturer,s Continued Growth and Compliance, ... a leader in the,design and development of Enterprise ... II Medical Manufacturing for its comprehensive ERP,software, EnterpriseIQ. ... medical,device manufacturing industry, so does the level of ...
... Center had sleeplessness, other problems, study shows , , TUESDAY, ... the World Trade Center terrorist attacks boosted behavioral problems ... researchers at the Mount Sinai School of Medicine in ... years of age who lived in or attended preschool ...
Cached Medicine News:Health News:West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 2Health News:BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessment Kits to U.S. School Children 2Health News:IPC The Hospitalist Company, Inc. Announces Closing of IPO and Exercise of Underwriters' Over-Allotment Option 2Health News:Senetek PLC Announces Debut of Pyratine-6(TM) at the Annual Meeting of the American Academy of Dermatology 2Health News:Phase II Medical Manufacturing Selects IQMS for ERP Solution 2Health News:Phase II Medical Manufacturing Selects IQMS for ERP Solution 3Health News:9/11 Exposure Linked to Behavior Trouble in Kids 2
(Date:6/1/2015)... , June 1, 2015 CEFALY Technology ... nerve stimulation device specifically authorized for use prior to ... from a new PET trial showing that the Cefaly ... the brain in migraine patients, namely the orbitofrontal cortex ... (PET) scan, which is an imaging test of the brain, used a ...
(Date:6/1/2015)... 2015 NSHOA Cancer Center and Heron ... positive, top-line results from its recently completed Phase ... safety of the Company,s 5-HT 3 receptor ... extended release) as part of a three-drug regimen ... receptor antagonist fosaprepitant and the IV corticosteroid dexamethasone ...
(Date:6/1/2015)... YORK , June 1, 2015   ... of Open, Transparent and Connected financial marketplaces for ... Incorporated, a San Diego -based ... traded on OTCQB®, America,s only public venture market ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO ...
Breaking Medicine Technology:New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2New cancer therapy study results - MAGIC Trial 2OTC Markets Group Congratulates OncoSec Medical on NASDAQ Listing 2
... SAN DIEGO, Aug. 16, 2011 Optimer Pharmaceuticals, Inc. ... subgroup analysis of patients receiving concomitant systemic antibiotics in ... DIFICID™ (fidaxomicin) tablets in the treatment of adult patients ... online in the September 1 issue of Clinical ...
... 16, 2011 CVS/pharmacy announced today that all ... Compliance Corp.,s Environmental Return System, which provides customers ... unused, expired or unwanted drugs using affordable medication ... The postage-paid envelopes cost $3.99 and allow customers ...
Cached Medicine Technology:Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 2Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 3Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 4Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 5Clinical Infectious Diseases Publishes Subgroup Analysis Showing Optimer's DIFICID™ (fidaxomicin) Tablets Exhibited Higher Clinical Cure and Global Cure Rates Than Vancomycin in Patients with Clostridium difficile-Associated Diarrhea (CDAD) Receivin 6CVS/pharmacy Offers Customers Safe Disposal Program for Medications 2CVS/pharmacy Offers Customers Safe Disposal Program for Medications 3
... with 3 charging wells. Available In 4 ... and Cinnamon. Spring balanced refractor and slit ... construction for lifelong quality. Sealed hydraulic system ... movement. Chair back reclines manually to fully ...
... the patented HydroKeratome corneal cutting device for ... industry experts believe it will replace the ... used in the LASIK refractive procedure. In ... has demonstrated that its proprietary technology is ...
Our 2.5v Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
3.5v Coaxial Ophthalmoscope Set with Convertible Handle and Hard Case. Our 3.5v Coaxial Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
Medicine Products: